The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Hematologic Diseases

Back to Details
This is a "connection" page, showing publications Kenneth S. Cohen has written about Hematologic Diseases.
Kenneth S. Cohen
Connection Strength
0.038
Hematologic Diseases
  1. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.